RIANA Therapeutics
PrivateLast Round
Seed
Feb 19, 2026
Total Funding Raised
$1.95M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
RIANA Therapeutics operates in Healthcare & Life Sciences and is based in Vienna. Its latest recorded funding round was a Grant round in February 2023.
RIANA Therapeutics is a biotechnology company that develops small-molecule cancer therapies targeting protein-protein interactions in transcription factors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RIANA Therapeutics Comparables
Compare RIANA Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| QUANTRO Therapeutics | 83% | |
| Eli Lilly and Company | 79% | |
| Bayer AG | 79% |
For institutional investors. Book with your work email.
RIANA Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 19, 2026 | ||||
| Grant | Feb 1, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
RIANA Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Vienna Business Agency | Grant |
| Austria Wirtschaftsservice | Grant |
| FFG Austrian Research Promotion Agency | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 75% MoM.
- Feb 19, 2026
$1.43M round raised
For institutional investors. Book with your work email.
RIANA Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about RIANA Therapeutics's valuation, stock price, and market status.
Is RIANA Therapeutics a public or private company?
RIANA Therapeutics is a private company.
What is the current stock price of RIANA Therapeutics?
RIANA Therapeutics is a private company, so its shares have no public market price. Caplight tracks RIANA Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is RIANA Therapeutics worth (valuation)?
Valuation information for RIANA Therapeutics is not publicly available.
Can I buy RIANA Therapeutics stock?
RIANA Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was RIANA Therapeutics's last funding round?
RIANA Therapeutics's most recent funding round was Seed on February 19, 2026.
Who are the main investors in RIANA Therapeutics?
Key investors in RIANA Therapeutics include Vienna Business Agency, Austria Wirtschaftsservice, FFG Austrian Research Promotion Agency.
Will RIANA Therapeutics IPO soon?
No public IPO plans have been announced for RIANA Therapeutics.
How can I track RIANA Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in RIANA Therapeutics's shares on secondary markets.